Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Fyles

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
Advances in Radiation Oncology|January 16, 2026
Clinical Outcomes and Institutional Experience of Ultrahypofractionated Radiation Therapy in Patients With Breast CancerHiba Othman, Aisling Barry, Anthony Fyles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19), Rebecca K S Wong, Nancy Paul, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 9, 2014
Predictors of breast radiotherapy plan modifications: quality assurance rounds in a large cancer centreTimothy Lymberiou, Susanne Galuszka, Grace Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|November 9, 2015
Sorafenib Increases Tumor Hypoxia in Cervical Cancer Patients Treated With Radiation Therapy: Results of a Phase 1 Clinical StudyMichael F Milosevic, Carol A Townsley, Naz Chaudary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148Amit M Oza, Elizabeth A Eisenhauer, Laurie Elit, et al.
Advances in Radiation Oncology|August 11, 2020
Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in CanadaChristine A Koch, Grace Lee, Zhihui A Liu, et al.
Plos One|July 18, 2013
MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancerChristine How, Angela B Y Hui, Nehad M Alajez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2023
Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast CancerMartin Sjöström, Anthony Fyles, Fei-Fei Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 17, 2016
A prospective study of DWI, DCE-MRI and FDG PET imaging for target delineation in brachytherapy for cervical cancerKathy Han, Jennifer Croke, Warren Foltz, et al.
The New England Journal of Medicine|February 12, 2010
Long-term results of hypofractionated radiation therapy for breast cancerTimothy J Whelan, Jean-Philippe Pignol, Mark N Levine, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Advances in Radiation Oncology|January 16, 2026
Clinical Outcomes and Institutional Experience of Ultrahypofractionated Radiation Therapy in Patients With Breast CancerHiba Othman, Aisling Barry, Anthony Fyles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19), Rebecca K S Wong, Nancy Paul, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 9, 2014
Predictors of breast radiotherapy plan modifications: quality assurance rounds in a large cancer centreTimothy Lymberiou, Susanne Galuszka, Grace Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|November 9, 2015
Sorafenib Increases Tumor Hypoxia in Cervical Cancer Patients Treated With Radiation Therapy: Results of a Phase 1 Clinical StudyMichael F Milosevic, Carol A Townsley, Naz Chaudary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148Amit M Oza, Elizabeth A Eisenhauer, Laurie Elit, et al.
Advances in Radiation Oncology|August 11, 2020
Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in CanadaChristine A Koch, Grace Lee, Zhihui A Liu, et al.
Plos One|July 18, 2013
MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancerChristine How, Angela B Y Hui, Nehad M Alajez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2023
Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast CancerMartin Sjöström, Anthony Fyles, Fei-Fei Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 17, 2016
A prospective study of DWI, DCE-MRI and FDG PET imaging for target delineation in brachytherapy for cervical cancerKathy Han, Jennifer Croke, Warren Foltz, et al.
The New England Journal of Medicine|February 12, 2010
Long-term results of hypofractionated radiation therapy for breast cancerTimothy J Whelan, Jean-Philippe Pignol, Mark N Levine, et al.
Pageof 14